Biodexa Receives US FDA Fast Track Designation for eRapa in Familial Adenomatous Polyposis Underscores unmet need for a therapeutic alternative with the potential to delay or prevent surgical ...

Biodexa Pharmaceuticals has announced that the US FDA has granted Fast Track designation for its drug eRapa, an encapsulated form of rapamycin, which is being developed for familial adenomatous ...

The designation was requested based on the potential for eRapa to address an unmet medical need for FAP, a condition which left untreated universally leads to colorectal cancer. Today, the only ...

The designation was requested based on the potential for eRapa to address an unmet medical need for FAP, a condition which left untreated universally leads to colorectal cancer. Today, the only ...

Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with ...

Let's be real for a second. Our attention spans aren't what they used to be. With the constant bombardment of content from all sides competing for our glances, our ears, and our fingers, it's no ...

U.S. stocks traded higher toward the end of trading, with the Dow Jones index jumping more than 150 points on Monday. The Dow traded up 0.40% to 44,482.54 while the NASDAQ gained 1.16% to 19,750.22.

What you eat and drink does more than fill your stomach — it also gives your body the nutrients it needs to thrive. Your overall diet can affect how you feel today as well as how you feel years ...